Genmab Interest Income from 2010 to 2026
| GMAB Stock | USD 28.18 0.52 1.88% |
Interest Income | First Reported 2019-03-31 | Previous Quarter 32 M | Current Value 48 M | Quarterly Volatility 282.1 M |
Check Genmab AS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genmab AS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 475.5 M, Interest Expense of 408.5 M or Selling General Administrative of 655.3 M, as well as many indicators such as Price To Sales Ratio of 4.87, Dividend Yield of 0.0 or PTB Ratio of 5.3. Genmab financial statements analysis is a perfect complement when working with Genmab AS Valuation or Volatility modules.
Genmab | Interest Income | Build AI portfolio with Genmab Stock |
Analyzing Genmab AS's Interest Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Interest Income has evolved provides context for assessing Genmab AS's current valuation and future prospects.
Latest Genmab AS's Interest Income Growth Pattern
Below is the plot of the Interest Income of Genmab AS over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Genmab AS's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genmab AS's overall financial position and show how it may be relating to other accounts over time.
| Interest Income | 10 Years Trend |
|
Interest Income |
| Timeline |
Genmab Interest Income Regression Statistics
| Arithmetic Mean | 209,171,706 | |
| Geometric Mean | 91,831,672 | |
| Coefficient Of Variation | 145.11 | |
| Mean Deviation | 208,154,491 | |
| Median | 62,922,000 | |
| Standard Deviation | 303,529,611 | |
| Sample Variance | 92130.2T | |
| Range | 967.9M | |
| R-Value | 0.58 | |
| Mean Square Error | 64950.7T | |
| R-Squared | 0.34 | |
| Significance | 0.01 | |
| Slope | 35,000,794 | |
| Total Sum of Squares | 1474083.6T |
Genmab Interest Income History
Other Fundumenentals of Genmab AS
Genmab AS Interest Income component correlations
Click cells to compare fundamentals
About Genmab AS Financial Statements
Genmab AS stakeholders use historical fundamental indicators, such as Genmab AS's Interest Income, to determine how well the company is positioned to perform in the future. Although Genmab AS investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genmab AS's assets and liabilities are reflected in the revenues and expenses on Genmab AS's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genmab AS. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Interest Income | 138 M | 131.1 M | |
| Net Interest Income | 77 M | 73.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:Check out the analysis of Genmab AS Correlation against competitors. For information on how to trade Genmab Stock refer to our How to Trade Genmab Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genmab AS. Market participants price Genmab higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Genmab AS assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.94) | Earnings Share 1.54 | Revenue Per Share | Quarterly Revenue Growth 0.03 | Return On Assets |
The market value of Genmab AS is measured differently than its book value, which is the value of Genmab that is recorded on the company's balance sheet. Investors also form their own opinion of Genmab AS's value that differs from its market value or its book value, called intrinsic value, which is Genmab AS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genmab AS's market value can be influenced by many factors that don't directly affect Genmab AS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genmab AS's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genmab AS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Genmab AS's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.